![April Manness](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
April Manness formerly worked at Luminor Medical Technologies, Inc., as Chief Financial Officer, Luminor Medical Technologies, Inc., as Chief Financial Officer in 2011, Kane Biotech, Inc., as Interim Chief Financial Officer from 2011 to 2012, and DiaMedica Therapeutics, Inc., as Chief Financial Officer.
Antiguos cargos conocidos de April Manness.
| Empresas | Cargo | Fin |
|---|---|---|
| KANE BIOTECH INC. | Director Financiero/CFO | 01/01/2012 |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Director Financiero/CFO | 23/12/2011 |
| DIAMEDICA THERAPEUTICS INC. | Director Financiero/CFO | - |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Director Financiero/CFO | 17/10/2007 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
4
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
Kane Biotech, Inc.
 Kane Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that manufactures animal health oral care products | Commercial Services |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
- Bolsa de valores
- Insiders
- April Manness
